Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kobold

Showing results (51-60 of 177) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Sciences|March 17, 2019
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T CellsMohamed-Reda Benmebarek, Clara Helke Karches, Bruno Loureiro Cadilha, et al.
Frontiers in Immunology|November 30, 2019
Interleukin-37 Inhibits Colon Carcinogensis During Chronic ColitisSteffeni Mountford, Andrea Ringleb, Rahel Schwaiger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2010
Cryptic epitopes induce high-titer humoral immune response in patients with cancerEliane Fischer, Sebastian Kobold, Sascha Kleber, et al.
Journal for Immunotherapy of Cancer|March 2, 2020
Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting reportCatarina Pinto, Michael Bergmann, Daria Briukhovetska, et al.
Cells|December 24, 2021
NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful DevelopmentAli Bashiri Dezfouli, Mina Yazdi, Alan Graham Pockley, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid TumorsAnne Holtermann, Mila Gislon, Martin Angele, et al.
Biological Chemistry|May 20, 2024
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapiesChristina Angeliki Tsiverioti, Adrian Gottschlich, Marcel Trefny, et al.
Human Vaccines & Immunotherapeutics|December 28, 2022
9th Immunotherapy of Cancer conference (ITOC): A meeting reportIman Dalloul, Thaddäus Jan Clemens Strzalkowski, Michael von Bergwelt-Baildon, et al.
International Journal of Cancer|June 23, 2023
Mechanisms and strategies for safe chimeric antigen receptor T-cell activity controlSophia Stock, Anna-Kristina Klüver, Luisa Fertig, et al.
Frontiers in Immunology|June 20, 2022
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung CancerPrameela Kandra, Rajender Nandigama, Bastian Eul, et al.
Pageof 18

Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Sciences|March 17, 2019
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T CellsMohamed-Reda Benmebarek, Clara Helke Karches, Bruno Loureiro Cadilha, et al.
Frontiers in Immunology|November 30, 2019
Interleukin-37 Inhibits Colon Carcinogensis During Chronic ColitisSteffeni Mountford, Andrea Ringleb, Rahel Schwaiger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2010
Cryptic epitopes induce high-titer humoral immune response in patients with cancerEliane Fischer, Sebastian Kobold, Sascha Kleber, et al.
Journal for Immunotherapy of Cancer|March 2, 2020
Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting reportCatarina Pinto, Michael Bergmann, Daria Briukhovetska, et al.
Cells|December 24, 2021
NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful DevelopmentAli Bashiri Dezfouli, Mina Yazdi, Alan Graham Pockley, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid TumorsAnne Holtermann, Mila Gislon, Martin Angele, et al.
Biological Chemistry|May 20, 2024
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapiesChristina Angeliki Tsiverioti, Adrian Gottschlich, Marcel Trefny, et al.
Human Vaccines & Immunotherapeutics|December 28, 2022
9th Immunotherapy of Cancer conference (ITOC): A meeting reportIman Dalloul, Thaddäus Jan Clemens Strzalkowski, Michael von Bergwelt-Baildon, et al.
International Journal of Cancer|June 23, 2023
Mechanisms and strategies for safe chimeric antigen receptor T-cell activity controlSophia Stock, Anna-Kristina Klüver, Luisa Fertig, et al.
Frontiers in Immunology|June 20, 2022
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung CancerPrameela Kandra, Rajender Nandigama, Bastian Eul, et al.
Pageof 18